Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.
about
Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomesDe-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shockFluid resuscitation for children with severe febrile illness and septic shock in resource-limited settingsDe-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shockQ24240274Human recombinant activated protein C for severe sepsisDelaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortalityBench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier?Strategies to Reduce Mortality from Bacterial Sepsis in Adults in Developing CountriesDelays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital studyAntibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance.Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot StudyAutomated extraction improves multiplex molecular detection of infection in septic patientsDirect identification of bacteria in positive blood culture bottles by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry.Analysis and presentation of cumulative antimicrobial susceptibility data (antibiograms): substantial variability across medical centers in the United States.Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosaSerum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary reportHigh-throughput and automated diagnosis of antimicrobial resistance using a cost-effective cellphone-based micro-plate reader.Bundled care for septic shock: an analysis of clinical trials.Real-time identification of bacteria and Candida species in positive blood culture broths by matrix-assisted laser desorption ionization-time of flight mass spectrometryRapid identification of bacteria from positive blood culture bottles by use of matrix-assisted laser desorption-ionization time of flight mass spectrometry fingerprintingClinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae.Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsisPseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatmentImpact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study.Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome.Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysisAppropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency MedicineGram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit.Extended-Infusion versus standard-infusion piperacillin-tazobactam for sepsis syndromes at a tertiary medical center.An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsisBarriers to the effective treatment of sepsis: antimicrobial agents, sepsis definitions, and host-directed therapies.Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study.Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis.A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods.Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study
P2860
Q22305929-9A1B9CDF-531D-4368-9EB5-BAF665F7D947Q24198268-2C27EB5C-9E2A-4F3A-982E-86F5E2A8871FQ24203806-7EDDBF39-787C-448D-B83E-A463E2869F75Q24235566-5C2976B0-591C-4F7B-BA59-4DC38DF5E2B6Q24240274-7F800DDC-D2E3-467A-A5EE-1077D3F8B613Q24242859-3619EBFF-1BDB-4D42-940A-AED966D66C77Q24530412-0DBBA470-7FDD-4A3A-A25A-574CEC0162E6Q24813204-A95F18C9-7671-41E5-ADDB-687FD5DF594EQ27003122-BF32F359-DC2A-4306-839C-50C032480B93Q27486641-C55C72AE-D9A6-4995-8AEA-428D29C5D107Q28534034-2D93C223-7809-4D7E-844F-E90E0E698ABFQ28545750-570BC21D-D965-4F8C-BEB3-D2EBFD27FA13Q28551453-9E74F29C-B19F-4823-A6CF-B612EF9D7332Q28748877-ED49FD2C-5F27-4F27-8340-92EB904EF583Q30927749-C5C22FA4-F57E-4E14-A99F-15F49B79B972Q31037016-DAF54E1D-E19F-4E18-BB7C-61BFC1EA897EQ33369556-740388D0-D9B5-4EC0-A440-54763993C172Q33424246-E7D2E6C6-AF5E-4580-B1D0-9E465E2F3FF6Q33433721-6482DCCC-566A-4465-B4E1-55FE16AD0233Q33451918-A5DC58CF-F3BA-4638-8D5B-F544441C428EQ33520432-D0042C57-13B4-49B3-A907-DFE1984A5A68Q33541806-824BABFC-1836-4CD4-88DC-BDF57B9F91C5Q33541809-5BA3621A-3883-4F76-9C55-EB72289B39ACQ33566287-835652B6-19FC-4561-9E10-B1386251217BQ33568677-4C86C3C2-7B76-4901-91E6-57335511BEA4Q33722082-3F389CE2-23FB-4C4B-B2A6-EA6CD46E0694Q33754099-1E6C3BB8-7BE3-4A60-A827-F768FAFA6DC0Q33803393-EE3FCDE9-C459-415B-8C44-042DD32F63EDQ33826400-AA37918B-0EE6-4BFE-9F6C-4F81CB997051Q33843533-C84CE993-E21E-4C0D-9483-78E40A526FD4Q33974292-CD1509EF-2A18-411C-A170-51B8AE143A39Q33988563-E0F9339E-A6C2-443D-BC9B-C7EDE9ED0335Q34003193-FBC06995-18F2-48A3-B72E-E720F419CCFAQ34058137-0250EF9A-9A9F-4A3F-B437-633666443838Q34194422-E9FF9074-CA6A-4892-986F-7DD30043049EQ34418911-CA3F7AE0-17E0-419A-B805-6BCC52F8F0F6Q34437954-C0DD2DC4-F56F-45CF-8F62-53076292D5AEQ34529198-30272D02-4C99-4619-B23D-7DEB59835E95Q34567560-F1603E53-52A2-4416-B6C3-DA970397A1ADQ34686057-41B5D1AF-BE2A-4731-8376-69C9C474846B
P2860
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@ast
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@en
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@nl
type
label
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@ast
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@en
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@nl
prefLabel
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@ast
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@en
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@nl
P2093
P1476
Inappropriate initial antimicr ...... ing therapy for severe sepsis.
@en
P2093
Daniel Lew
Jacques A Romand
Jorge Garbino
Jérome Pugin
P304
P356
10.1016/J.AMJMED.2003.07.005
P407
P577
2003-11-01T00:00:00Z